<DOC>
	<DOCNO>NCT02843399</DOCNO>
	<brief_summary>Primary objective study compare diabetes-related healthcare utilization cost patient initiate exenatide weekly v insulin glargine .</brief_summary>
	<brief_title>Economic Outcomes EQW ( Exenatide Once Weekly ) vs. IG ( Insulin Glargine ) T2D Patients Who Are New Injectable Therapy</brief_title>
	<detailed_description>This retrospective , observational cohort analysis assess medical pharmacy claim adult patient type 2 diabetes Truven Health MarketScanÂ® Commercial Medicare Supplemental claim database 2011 2015 . Diabetes-related healthcare utilization cost measure primary outcome . Secondary outcome include all-cause healthcare utilization cost , major adverse cardiovascular event ( MACE ) -related utilization cost , medically attend hypoglycemia event .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1 . One outpatient prescription claim EQW ( Exenatide Once Weekly ) vs. IG ( Insulin Glargine ) February 1 , 2012 , June 30 , 2014 ( date first claim = index date ; medication first claim corresponds = index therapy ) . 2 . Aged 18 old index date . 3 . Continuous enrollment medical pharmacy benefit 12 month ( baseline period ) 12 month ( followup period ) index date . ( 6 month followup provide determine effect sample size . ) 4 . One medical claim diagnosis code T2DM ( ICD9CM 250.x0 250.x2 ) baseline period index date . 1 . No outpatient prescription claim injectable glucoselowering medication baseline period ( GLP1RA insulins ) . 2 . No medical claim diagnosis ( procedure , appropriate ) code indicative type 1 diabetes mellitus ( ICD9CM 250.x1 250.x3 ) , gestational diabetes ( ICD9CM 648.8x ) , pregnancy childbirth baseline followup period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetes Mellitus Type 2</keyword>
</DOC>